Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017

  • ID: 4436065
  • Report
  • Region: Global
  • 1575 Pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Bioasis Technologies Inc
  • Erytech Pharma SA
  • Kringle Pharma Inc
  • Onconova Therapeutics Inc
  • Scancell Holdings Plc
  • MORE
Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

Glioblastoma also known as glioblastoma multiforme is a fast-growing glioma that develops from star-shaped glial cells that support the health of the nerve cells within the brain. Symptoms include headaches, blurred vision, nausea, vomiting, memory loss, speech difficulty, muscle weakness and loss of appetite. Risk factors include gender (male) and age. Treatment includes surgery, radiation therapy and chemotherapy.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Glioblastoma Multiforme (GBM) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Glioblastoma Multiforme (GBM) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Glioblastoma Multiforme (GBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies / Universities / Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 11, 106, 65, 1, 8, 155, 23 and 6 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 12, 14, 1, 36 and 11 molecules, respectively.

Glioblastoma Multiforme (GBM) (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Glioblastoma Multiforme (GBM) (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Glioblastoma Multiforme (GBM) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Glioblastoma Multiforme (GBM) (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Glioblastoma Multiforme (GBM) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Glioblastoma Multiforme (GBM) (Oncology).
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Glioblastoma Multiforme (GBM) (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Glioblastoma Multiforme (GBM) (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc
  • Bioasis Technologies Inc
  • Erytech Pharma SA
  • Kringle Pharma Inc
  • Onconova Therapeutics Inc
  • Scancell Holdings Plc
  • MORE
Introduction

Glioblastoma Multiforme (GBM) - Overview

Glioblastoma Multiforme (GBM) - Therapeutics Development

Glioblastoma Multiforme (GBM) - Therapeutics Assessment

Glioblastoma Multiforme (GBM) - Companies Involved in Therapeutics Development

Glioblastoma Multiforme (GBM) - Drug Profiles

Glioblastoma Multiforme (GBM) - Dormant Projects

Glioblastoma Multiforme (GBM) - Discontinued Products

Glioblastoma Multiforme (GBM) - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Glioblastoma Multiforme (GBM), H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Products under Development by Companies, H2 2017

Products under Development by Universities/Institutes, H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by AbbVie Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Accurexa Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Actuate Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Aduro BioTech Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Advantagene Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Advenchen Laboratories LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Affimed GmbH, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Agenus Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ambrx Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Amgen Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ampio Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by AngioChem Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Apac Biotech Pvt Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by apceth Biopharma GmbH, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by APIM Therapeutics AS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Apogenix AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ariad Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Arog Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Astellas Pharma Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by AstraZeneca Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Athenex Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Basilea Pharmaceutica Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Batu Biologics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Bayer AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Beactica AB, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by BeiGene Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Berg LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Bexion Pharmaceuticals LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by BeyondSpring Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Bio-Path Holdings Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Bioasis Technologies Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by BioCancell Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Biovista Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Boehringer Ingelheim GmbH, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Boston Biomedical Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Bristol-Myers Squibb Co, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Cantex Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Cavion LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Celgene Corp, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Celldex Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Cellmid Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Celsion Corp, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ChemoCentryx Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Coherus BioSciences Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Cortice Biosciences Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Critical Outcome Technologies Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Curtana Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Cynata Therapeutics Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by CytoVac AS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Daiichi Sankyo Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Deciphera Pharmaceuticals LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by DEKK-TEC Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by DelMar Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Diffusion Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ecrins Therapeutics SAS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Eisai Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Eli Lilly and Co, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by EnGeneIC Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Enterome Bioscience SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by EntreChem SL, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ERC Belgium SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Erytech Pharma SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Evotec AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by F-star Biotechnology Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by FirstString Research Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Fujifilm Holdings Corporation, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Gene Techno Science Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Genentech Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Genisphere LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Genor BioPharma Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by GlaxoSmithKline Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by GlioPharma ApS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by GtreeBNT Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by GW Pharmaceuticals Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Hamlet Pharma AB, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Humanigen Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Hutchison MediPharma Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Immatics Biotechnologies GmbH, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Immune Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ImmunoCellular Therapeutics Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Immunomedics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Immunomet Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Immunomic Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Incyte Corp, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Infinity Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Innovation Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Inovio Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Inspyr Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Insys Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Iovance Biotherapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ipsen SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Janpix Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Johnson & Johnson, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Juno Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Kadmon Corp LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Karyopharm Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Kazia Therapeutics Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Kite Pharma Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Komipharm International Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Kringle Pharma Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Les Laboratoires Servier SAS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Lixte Biotechnology Holdings Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Loxo Oncology Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Mabion SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by MacroGenics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Medesis Pharma SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Medicenna Therapeutics Corp, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by MedImmune LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Merck & Co Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Merck KGaA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Midatech Pharma Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Millennium Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by MimiVax LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Molecular Templates Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Moleculin Biotech Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Mycenax Biotech Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by NanoCarrier Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Nanomerics Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Nektar Therapeutics, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Neonc Technologies Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by NewLink Genetics Corp, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Northwest Biotherapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Novartis AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Noxopharm Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Noxxon Pharma AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Nuo Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by NuvOx Pharma LLC, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Omniox Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Oncobiologics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Oncodesign SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Onconova Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by OncoResponse Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Oncternal Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ono Pharmaceutical Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Orphit SAS, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Oryx GmbH & Co KG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Ovensa Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Peloton Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Peptomyc SL, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Peregrine Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Pfizer Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Pharma Mar SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by PharmAbcine Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by PharmaCyte Biotech Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Pharmicell Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Phoenix Biotechnology Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by PIQUR Therapeutics AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Plex Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Plexxikon Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Prana Biotechnology Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by PTC Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Puma Biotechnology Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Regulus Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ReNeuron Group Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Rgenix Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Richter Gedeon Nyrt, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sanofi, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sapience Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Scancell Holdings Plc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sellas Life Sciences Group Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sigma-Tau SpA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by SignPath Pharma Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Silenseed Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by SOM Biotech SL, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sorrento Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by StemGen SpA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Stemline Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Sunesis Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Susavion Biosciences Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Symphogen A/S, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Synactix Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Systimmune Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Terpenoid Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Theralase Technologies Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Therapeia GmbH & Co KG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Tocagen Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by TRACON Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Transgene SA, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Trillium Therapeutics Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by TVAX Biomedical Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Tyme Technologies Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Upsher-Smith Laboratories Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Vascular Biogenics Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Vault Pharma Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Vaximm AG, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by VBI Vaccines Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by VCN Biosciences SL, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ViraTherapeutics GmbH, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Vyriad Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by X4 Pharmaceuticals Inc, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Xintela AB, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by Yooyoung Pharm Co Ltd, H2 2017

Glioblastoma Multiforme (GBM) - Pipeline by ZIOPHARM Oncology Inc, H2 2017

Glioblastoma Multiforme (GBM) - Dormant Projects, H2 2017

Glioblastoma Multiforme (GBM) - Discontinued Products, H2 2017

List of Figures

Number of Products under Development for Glioblastoma Multiforme (GBM), H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Top 10 Routes of Administration, H2 2017

Number of Products by Stage and Top 10 Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AbbVie Inc
  • Accurexa Inc
  • Actuate Therapeutics Inc
  • Aduro BioTech Inc
  • Advantagene Inc
  • Advenchen Laboratories LLC
  • Affimed GmbH
  • Agenus Inc
  • Ambrx Inc
  • Amgen Inc
  • Ampio Pharmaceuticals Inc
  • AngioChem Inc
  • Apac Biotech Pvt Ltd
  • apceth Biopharma GmbH
  • APIM Therapeutics AS
  • Apogenix AG
  • Ariad Pharmaceuticals Inc
  • Arog Pharmaceuticals Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Athenex Inc
  • Basilea Pharmaceutica Ltd
  • Batu Biologics Inc
  • Bayer AG
  • Beactica AB
  • BeiGene Ltd
  • Berg LLC
  • Bexion Pharmaceuticals LLC
  • BeyondSpring Pharmaceuticals Inc
  • Bio-Path Holdings Inc
  • Bioasis Technologies Inc
  • BioCancell Ltd
  • Biovista Inc
  • Boehringer Ingelheim GmbH
  • Boston Biomedical Inc
  • Bristol-Myers Squibb Co
  • Cantex Pharmaceuticals Inc
  • Cavion LLC
  • Celgene Corp
  • Celldex Therapeutics Inc
  • Cellmid Ltd
  • Celsion Corp
  • ChemoCentryx Inc
  • Coherus BioSciences Inc
  • Cortice Biosciences Inc
  • Critical Outcome Technologies Inc
  • Curtana Pharmaceuticals Inc
  • Cynata Therapeutics Ltd
  • CytoVac AS
  • Daiichi Sankyo Co Ltd
  • Deciphera Pharmaceuticals LLC
  • DEKK-TEC Inc
  • DelMar Pharmaceuticals Inc
  • Diffusion Pharmaceuticals Inc
  • Dr. Reddy's Laboratories Ltd
  • Ecrins Therapeutics SAS
  • Eisai Co Ltd
  • Eli Lilly and Co
  • EnGeneIC Ltd
  • Enterome Bioscience SA
  • EntreChem SL
  • ERC Belgium SA
  • Erytech Pharma SA
  • Evotec AG
  • F-star Biotechnology Ltd
  • F. Hoffmann-La Roche Ltd
  • FirstString Research Inc
  • Fujifilm Holdings Corporation
  • Gene Techno Science Co Ltd
  • Genentech Inc
  • Genisphere LLC
  • Genor BioPharma Co Ltd
  • GlaxoSmithKline Plc
  • GlioPharma ApS
  • GtreeBNT Co Ltd
  • GW Pharmaceuticals Plc
  • Hamlet Pharma AB
  • Hanmi Pharmaceuticals Co Ltd
  • Humanigen Inc
  • Hutchison MediPharma Ltd
  • Immatics Biotechnologies GmbH
  • Immune Pharmaceuticals Inc
  • ImmunoCellular Therapeutics Ltd
  • Immunomedics Inc
  • Immunomet Therapeutics Inc
  • Immunomic Therapeutics Inc
  • Incyte Corp
  • Infinity Pharmaceuticals Inc
  • Innovation Pharmaceuticals Inc
  • Inovio Pharmaceuticals Inc
  • Inspyr Therapeutics Inc
  • Insys Therapeutics Inc
  • Iovance Biotherapeutics Inc
  • Ipsen SA
  • Janpix Inc
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Johnson & Johnson
  • Juno Therapeutics Inc
  • Kadmon Corp LLC
  • Karyopharm Therapeutics Inc
  • Kazia Therapeutics Ltd
  • Kite Pharma Inc
  • Komipharm International Co Ltd
  • Kringle Pharma Inc
  • Kyorin Pharmaceutical Co Ltd
  • Les Laboratoires Servier SAS
  • Lixte Biotechnology Holdings Inc
  • Loxo Oncology Inc
  • Mabion SA
  • MacroGenics Inc
  • Medesis Pharma SA
  • Medicenna Therapeutics Corp
  • MedImmune LLC
  • Merck & Co Inc
  • Merck KGaA
  • Midatech Pharma Plc
  • Millennium Pharmaceuticals Inc
  • MimiVax LLC
  • Molecular Templates Inc
  • Moleculin Biotech Inc
  • Mycenax Biotech Inc
  • NanoCarrier Co Ltd
  • Nanomerics Ltd
  • Nektar Therapeutics
  • Neonc Technologies Inc
  • NewLink Genetics Corp
  • Northwest Biotherapeutics Inc
  • Novartis AG
  • Noxopharm Ltd
  • Noxxon Pharma AG
  • Nuo Therapeutics Inc
  • NuvOx Pharma LLC
  • Omniox Inc
  • Oncobiologics Inc
  • Oncodesign SA
  • Onconova Therapeutics Inc
  • OncoResponse Inc
  • Oncternal Therapeutics Inc
  • Ono Pharmaceutical Co Ltd
  • Orphit SAS
  • Oryx GmbH & Co KG
  • Ovensa Inc
  • Peloton Therapeutics Inc
  • Peptomyc SL
  • Peregrine Pharmaceuticals Inc
  • Pfizer Inc
  • Pharma Mar SA
  • PharmAbcine Inc
  • PharmaCyte Biotech Inc
  • Pharmicell Co Ltd
  • Phoenix Biotechnology Inc
  • PIQUR Therapeutics AG
  • Plex Pharmaceuticals Inc
  • Plexxikon Inc
  • Prana Biotechnology Ltd
  • PTC Therapeutics Inc
  • Puma Biotechnology Inc
  • Regulus Therapeutics Inc
  • ReNeuron Group Plc
  • Rgenix Inc
  • Richter Gedeon Nyrt
  • Sanofi
  • Sapience Therapeutics Inc
  • Scancell Holdings Plc
  • Sellas Life Sciences Group Ltd
  • Sigma-Tau SpA
  • SignPath Pharma Inc
  • Silenseed Ltd
  • SOM Biotech SL
  • Sorrento Therapeutics Inc
  • StemGen SpA
  • Stemline Therapeutics Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • Sunesis Pharmaceuticals Inc
  • Susavion Biosciences Inc
  • Symphogen A/S
  • Synactix Pharmaceuticals Inc
  • Systimmune Inc
  • Terpenoid Therapeutics Inc
  • Theralase Technologies Inc
  • Therapeia GmbH & Co KG
  • Tocagen Inc
  • TRACON Pharmaceuticals Inc
  • Transgene SA
  • Trillium Therapeutics Inc
  • TVAX Biomedical Inc
  • Tyme Technologies Inc
  • Upsher-Smith Laboratories Inc
  • Vascular Biogenics Ltd
  • Vault Pharma Inc
  • Vaximm AG
  • VBI Vaccines Inc
  • VCN Biosciences SL
  • ViraTherapeutics GmbH
  • Vyriad Inc
  • X4 Pharmaceuticals Inc
  • Xintela AB
  • Yooyoung Pharm Co Ltd
  • ZIOPHARM Oncology Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll